Crescent Capital BDC Inc (CCAP) Price Prediction & ForecastCCAPForecastCrescent Capital BDC Inc

Alphio's CCAP stock price prediction model matches the current Crescent Capital BDC Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.62 (+0.74%). The 1-week path is $10.71 (+1.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Crescent Capital BDC Inc (CCAP) is not a good buy right now due to its declining financial performance and negative market sentiment. The current price is $10.54, which is significantly below the average price target of $12.50 set by analysts. The company has reported a net income loss of $15.5 million in Q1 2026 and $3.25 million in Q2 2026, indicating ongoing financial struggles. Additionally, the RSI is at 26.53, suggesting that the stock is oversold, but this could indicate further downside risk rather than an immediate buying opportunity. The main risk is the significant drop in net asset value per share, which decreased to $17.82, marking the eighth consecutive quarterly decline, primarily due to unrealized losses on investments. Overall, the combination of poor earnings, a high forward P/E of 55.56, and a recent dividend cut of 19% makes CCAP a sell for long-term investors.

Crescent Capital BDC Inc (CCAP) last closed at $10.54, losing -0.57%. These facts feed the 1-day and 1-week CCAP price prediction above.